---
title: "Weekly Recap | MOAT.US -0.89%, lighter-volume pullback"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299518550.md"
description: "MOAT.US fell 0.89% this week to close at $107.57, underperforming the S&P 500’s -0.08% by about 0.81 percentage points. The fund opened at $108.985, hit an intraday high of $110.22 on Monday, and then drifted lower through Tuesday and Wednesday. Friday brought a notable volume spike of over 956,000 shares, with the price slipping to $107.40 before settling at $107.57, near the week’s low. Average daily turnover came in about 15."
datetime: "2026-09-19T07:40:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299518550.md)
  - [en](https://longbridge.com/en/news/299518550.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299518550.md)
generator: "portal-rs"
---

# Weekly Recap | MOAT.US -0.89%, lighter-volume pullback

## The Week

MOAT.US fell 0.89% this week to close at $107.57, underperforming the S&P 500’s -0.08% by about 0.81 percentage points. The fund opened at $108.985, hit an intraday high of $110.22 on Monday, and then drifted lower through Tuesday and Wednesday. Friday brought a notable volume spike of over 956,000 shares, with the price slipping to $107.40 before settling at $107.57, near the week’s low. Average daily turnover came in about 15.79% below the recent median, marking a lighter-volume week. The fund remains within its 60-day range of $101.85 to $115.58.

## Sector News

The week’s flow concentrated on AI and healthcare. On the AI side, Palantir and Nvidia moved to curb model use over data concerns, OpenAI and Microsoft fended off part of a software-developer lawsuit, and Anthropic said Claude now leads 26% of its AI R&D. Nebius raised AI cloud prices again on surging computing demand. In healthcare, Bristol Myers Squibb sued Amgen over a proposed Opdivo biosimilar and released two-year efficacy data on an arthritis drug. Danaher gained 5.83% on the week with consensus target above spot, while Jefferies maintained a buy rating. Broader market commentary flagged a rotation towards cash-returning stocks and away from megacaps.

## The Week Ahead

US macro data arrives in a cluster next week: Richmond Fed composite index on Tuesday, EIA crude and Cushing inventories on Wednesday, then initial jobless claims, current account balance, new home sales, and EIA natural gas storage on Thursday. In index news, Sandisk joins the S&P 100 on Monday as Nike leaves the same day, a change that could trigger passive flows across related funds.

## In Short

The fund’s week holds two competing signals. AI and healthcare news stayed active, with strength in names such as Danaher, while a rotation from megacap tech towards cash-returning stocks surfaced in market commentary. Friday’s volume spike near the weekly low points to growing disagreement among buyers and sellers. The question for next week is whether the macro calendar and the S&P 100 reshuffle reinforce that rotation or pull money back towards growth.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [MOAT.US](https://longbridge.com/en/quote/MOAT.US.md)

## Related News & Research

- [$100 Invested In Corning 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/299663577.md)
- [USA Rare Earth Rides Greenland Rally — But It Owns Nothing There](https://longbridge.com/en/news/299652247.md)
- [ANALYSIS-Big to get bigger: India's UPI fee shift to entrench dominant incumbents](https://longbridge.com/en/news/299727281.md)
- [Greenland Resources eyes US exchange listing after US-Denmark deal](https://longbridge.com/en/news/299663759.md)
- [Tesla Roadster Speculation Grows After FAA Sets 10,000-Foot Airspace Restriction](https://longbridge.com/en/news/299677194.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**